UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Acute hepatitis C: Current status and remaining challenges

Journal of hepatology, 2008-10, Vol.49 (4), p.625-633

2008

Link zum Volltext

Verfügbarkeit prüfen

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

The Journal of experimental medicine, 2013-06, Vol.210 (6), p.1109-1116

2013

Link zum Volltext

Verfügbarkeit prüfen

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Gastroenterology (New York, N.Y. 1943), 2006-04, Vol.130 (4), p.1086-1097

2006

Link zum Volltext

Verfügbarkeit prüfen

Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis

Journal of hepatology, 2011-09, Vol.55 (3), p.529-535

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

Clinical infectious diseases, 2005-04, Vol.40 (Supplement-5), p.S330-S335

2005

Link zum Volltext

Verfügbarkeit prüfen

Antigen kinetics determines immune reactivity

Proceedings of the National Academy of Sciences - PNAS, 2008-04, Vol.105 (13), p.5189-5194

2008

Link zum Volltext

Verfügbarkeit prüfen

Association of Hepatitis C Virus—Specific CD8+ T Cells with Viral Clearance in Acute Hepatitis C

The Journal of infectious diseases, 2000-05, Vol.181 (5), p.1528-1536

2000

Link zum Volltext

Verfügbarkeit prüfen

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy

Hepatology (Baltimore, Md.), 2012-04, Vol.55 (4), p.1038-1047

2012

Link zum Volltext

Verfügbarkeit prüfen

Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1

The American journal of gastroenterology, 2013-07, Vol.108 (7), p.1176-1178

2013

Link zum Volltext

Verfügbarkeit prüfen

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

Journal of Virology, 2001-06, Vol.75 (12), p.5550-5558

2001

Link zum Volltext

Verfügbarkeit prüfen

Hot topics in liver transplantation: Organ allocation – extended criteria donor – living donor liver transplantation

Journal of hepatology, 2008, Vol.48, p.S58-S67

2008

Link zum Volltext

Verfügbarkeit prüfen

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients

Hepatology (Baltimore, Md.), 2009-08, Vol.50 (2), p.369-377

2009

Link zum Volltext

Verfügbarkeit prüfen

The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection

Journal of gastroenterology, 2011-12, Vol.46 (12), p.1427-1436

2011

Link zum Volltext

Verfügbarkeit prüfen

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

Hepatology (Baltimore, Md.), 2005-03, Vol.41 (3), p.643-651

2005

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C

Journal of Virology, 2004-09, Vol.78 (17), p.9030-9040

2004

Link zum Volltext

Verfügbarkeit prüfen

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Gastroenterology (New York, N.Y. 1943), 2003-07, Vol.125 (1), p.80-88

2003

Link zum Volltext

Verfügbarkeit prüfen

Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses

Journal of viral hepatitis, 2006-10, Vol.13 (10), p.708-714

2006

Link zum Volltext

Verfügbarkeit prüfen

Detection of functionally altered hepatitis C virus-specific CD4 + T cells in acute and chronic hepatitis C

Hepatology (Baltimore, Md.), 2003-05, Vol.37 (5), p.1189-1198

2003

Link zum Volltext

Verfügbarkeit prüfen

Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

Annals of hepatology, 2013-03, Vol.12 (2), p.190-198

2013

Link zum Volltext

Verfügbarkeit prüfen

Telaprevir for Retreatment of HCV Infection

The New England journal of medicine, 2011-06, Vol.364 (25), p.2417-2428

2011

Link zum Volltext

Verfügbarkeit prüfen

Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C

Hepatology (Baltimore, Md.), 2000-09, Vol.32 (3), p.610-617

2000

Link zum Volltext

Verfügbarkeit prüfen

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

Hepatology (Baltimore, Md.), 2010-12, Vol.52 (6), p.1934-1947

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine

Vaccine, 2007-06, Vol.25 (26), p.4960-4966

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(84)
Japanisch
(11)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute hepatitis C: Current status and remaining challenges

A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

Antigen kinetics determines immune reactivity

Association of Hepatitis C Virus—Specific CD8+ T Cells with Viral Clearance in Acute Hepatitis C

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy

Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

Hot topics in liver transplantation: Organ allocation – extended criteria donor – living donor liver transplantation

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients

Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection

The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses

Detection of functionally altered hepatitis C virus-specific CD4 + T cells in acute and chronic hepatitis C

Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

Telaprevir for Retreatment of HCV Infection

Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine

Suchergebnisse filtern